Genetic testing to help diagnose ovarian or uterine cancer earlier
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests genetic (DNA) information to help doctors identify ovarian or uterine (endometrial) cancer sooner. You may be asked to do this around the time of planned surgery, when tissue is removed and can be checked for genetic clues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have suspected or confirmed cancer of the upper parts of the female reproductive tract (ovary or endometrium/uterus lining).
- You are scheduled to have surgery to remove a tumor.
- OR you are scheduled for hysterectomy to remove the uterus, usually for a condition thought to be non-cancer (benign).
- Your surgery plan includes removal of both fallopian tubes (bilateral salpingectomy).
- Your surgery may also include removal of both ovaries (bilateral oophorectomy), if your surgeon recommends it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain genetic mutations can help predict the risk of getting ovarian cancer. It aims to better understand how these inherited changes lead to the disease, which could help with early detection and prevention.
This study collects tissue samples and medical information from people at higher risk for ovarian cancer or undergoing gynecologic surgery. Researchers use this data to develop better ways to detect and prevent ovarian cancer early.
This study looks at genetic changes in ovarian cancer to find possible targeted treatments. It may help you if you have certain types of ovarian cancer and are seeking more personalized care.
This study tests a multimedia tool designed to help people with ovarian or endometrial cancer understand and decide about genetic testing. The tool may make it easier to learn about genetic testing options and make informed choices.
This study checks whether a special blood test (circulating tumor DNA) can help find ovarian cancer when it’s suspected. It may help doctors diagnose more accurately and sooner, so the right treatment can start sooner.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
Hear when a new Ovarian Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.